GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
N

Nanoform Finland Oyj NANOFH.HE · EUR

Health Care · Nasdaq Helsinki · 🇫🇮 Finland

Compare

0.77

+10.73%

Close of 9 Nov 2026, in EUR

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in EUR, from our data supplier.

FY2025

Revenue

€3.5m

FY2017FY2025

Net income

−€17.9m

FY2017FY2025

Free cash flow

−€18.7m

FY2017FY2025

Shareholders' equity

€42.8m

FY2017FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Revenue€3.5m€2.8m€2.6m€3.5m€2.0m€686,748€49,093€235,000€65,000
Research and development€5.9m€1.6m€998,885€1.0m€930,100€1.4m€27,521€865,000€452,000
Operating income−€22.3m−€24.2m−€22.5m−€21.6m−€19.7m−€19.2m−€7.4m−€2.0m−€486,115
Net income−€17.9m−€23.4m−€20.8m−€22.1m−€19.7m−€19.4m−€7.7m−€2.1m−€521,273
Diluted earnings per share-0.20-0.29-0.26-0.29-0.26-0.28-0.18-0.02-0.01

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Total assets€54.0m€71.8m€78.1m€100.6m€99.4m€73.9m€12.9m€8.2m€792,934
Cash and short-term investments€24.0m€41.5m€47.5m€68.7m€75.7m€61.0m€7.3m€5.6m€98,007
Total liabilities€11.2m€11.8m€11.2m€13.4m€14.9m€11.3m€5.0m€3.2m€1.0m
Debt€6.2m€5.6m€6.3m€6.9m€7.7m€6.9m€3.7m€2.4m€753,595
Shareholders' equity€42.8m€60.0m€66.9m€87.2m€84.5m€62.6m€7.9m€5.0m−€246,961
Shares outstanding91m81m78m77m75m69m43m86m86m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Cash from operations−€17.7m−€18.3m−€18.0m−€20.1m−€14.3m−€14.2m−€5.8m−€1.5m−€669,177
Capital spending−€1.0m−€1.7m−€3.8m−€9.1m−€7.9m−€2.4m−€1.9m−€440,668−€92,021
Free cash flow−€18.7m−€20.0m−€21.8m−€29.2m−€22.3m−€16.6m−€7.7m−€1.9m−€761,198
Dividends paid——————−€237,399——

Latest quarters

By quarter end

Jun 2026Mar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024
Revenue€775,000€1.3m€1.3m€662,000€667,000€876,000€750,502€774,000
Operating income−€3.5m−€3.9m−€4.6m−€5.0m−€5.7m−€5.7m−€6.2m−€4.8m
Net income−€3.7m−€3.4m−€1.8m−€4.8m−€6.0m−€5.4m−€5.7m−€5.5m
Diluted earnings per share-0.04-0.04-0.02-0.05-0.07-0.06-0.07-0.07
Cash from operations−€1.0m−€3.0m−€5.0m−€3.0m−€4.0m−€4.0m−€4.0m−€3.0m
Total assets€48.0m€50.7m€54.0m€57.1m€62.3m€66.6m€71.8m€76.7m
Cash and short-term investments€19.0m€20.5m€24.0m€29.5m€33.3m€37.0m€41.5m€46.2m
Debt€3.1m€2.7m€6.2m€6.5m€7.3m€5.4m€5.6m€5.7m
Shareholders' equity€36.3m€39.7m€42.8m€44.6m€49.3m€55.0m€60.0m€65.6m

Growth per year

Compound annual rate

3 years5 years10 years
Revenue0.6%38.9%—
Operating income0.9%3.0%—
Net income-6.8%-1.6%—

Valuation history

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020
Price to earnings-6.0-4.8-6.0-11.2-25.1-25.2
Price to sales30.140.648.370.7253.2—

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.